What does Birchview Capital, LP hold? Q1 2026 13F Holdings & Portfolio

AI Analysis · Q1 2026 · Q1 2026

Birchview Capital, LP filed its latest 13F-HR for Q1 2026. See the latest holdings and position changes below.

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight

KLA CORPORATION

$29M20K16.7%

BRISTOL-MYERS SQUIBB CO

$19M306K10.6%

COMPASS THERAPEUTICS INC

$8M1.5M4.4%

LAM RESEARCH CORPORATION

$8M36K4.4%

STOKE THERAPEUTICS INC

$7M210K3.9%

OVINTIV INC

$6M108K3.6%

INTELLIA THERAPEUTICS INC

$6M445K3.3%

STRUCTURE THERAPEUTICS INC

$5M100K2.7%

SOLID BIOSCIENCES INC

$5M626K2.6%

PROTHENA CORP PLC

$4M449K2.5%

Filing history loading…